Biopharmaceutical firm developing and commercializing therapies for patient outcomes worldwide.
Annual revenue $34,667 Latest available
Total funding - Funding intelligence
Employees 42 Tracked headcount
Investors - Known backers
Products 2 Services tracked
Competitors 9 Brand Intelligence

About Vidgas

Vidgas is a company based in Hyderabad (India) by Vinod Hegde. It operates as a B2B. The company has 42 employees as of March 31, 2023. Vidgas offers products and services including API Intermediates and ((3aR,4R,6R,6aR)-2,2-dimethyl-6-(2-oxo-4-(1H-1,2,4-triazol-1-yl)pyrimidin-1(2H)-yl)tetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methyl isobutyrate. Vidgas operates in a competitive market with competitors including Pharmaron, Lonza, Pfizer, Boehringer Ingelheim and LabConnect, among others.

  • Headquarter Hyderabad, India
  • Employees 42 as on 31 Mar, 2023
  • Founders Vinod Hegde
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Legal Name Vidgas Science & Technologies Private Limited
  • Date of Incorporation 14 Mar, 2013
  • Jurisdiction Hyderabad, Telangana, India
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $34.67 K (USD)
    -85.37
    as on Mar 31, 2023
  • Net Profit
    -$285.95 K (USD)
    -15.63
    as on Mar 31, 2023
  • EBITDA
    -$254.4 K (USD)
    -15.3
    as on Mar 31, 2023
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    42

    as on Mar 31, 2023

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Vidgas

Vidgas offers a comprehensive portfolio of products and services, including API Intermediates and ((3aR,4R,6R,6aR)-2,2-dimethyl-6-(2-oxo-4-(1H-1,2,4-triazol-1-yl)pyrimidin-1(2H)-yl)tetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methyl isobutyrate.

Product name locked
Category locked
Primary

Chemical intermediates used in drug manufacturing processes

Product name locked
Category locked
Locked

Specific intermediate for biopharmaceutical development applications

Funding Insights of Vidgas

Premium access

Detailed funding history for Vidgas

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Vidgas

Investments
Premium access

Investment portfolio details for Vidgas

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Vidgas

Premium access

Detailed financials for Vidgas

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Vidgas Comparisons

Vidgas Primary company
Description
Biopharmaceutical firm developing and commercializing therap...
Location
Hyderabad, India
Founded Year
-
Annual Revenue
$34.67 K (USD)
Net Profit
-$285.95 K (USD)
EBITDA
-$254.4 K (USD)
Employees
42
As of 2023
Premium access

Peer comparison for Vidgas

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Vidgas

Vidgas operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Pharmaron, Lonza, Pfizer, Boehringer Ingelheim and LabConnect, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Drug discovery and development services for small molecules are provided.
Locked Locked Locked
CDMO services for pharma, biotech, and specialty ingredients are provided.
Locked Locked Locked
Pharmaceutical products for treating multiple diseases are provided.
Locked Locked Locked
Generic drugs and clinical research services are provided globally.
Locked Locked Locked
Laboratory testing, clinical trial research, and biopharma services are provided.
Locked Locked Locked
AI powered scientific data management and workflow automation solutions
Premium access

Detailed competitors of Vidgas

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Vidgas

Premium access

Complete news archive for Vidgas

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vidgas

Vidgas is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.

As of Mar 31, 2023, the latest employee count at Vidgas is 42.

Annual revenue of Vidgas is $34.67K as on Mar 31, 2023.

VIDGASTECH is a biopharmaceutical company based in India and the USA, specializing in the discovery, development, and commercialization of innovative therapies to enhance patient outcomes. They conduct research and manufacturing of API intermediates, with facilities in Hyderabad and Yadgir, India, and Bridgewater, New Jersey. The company serves global healthcare needs through specialized pharmaceutical processes and collaborations.

Vidgas's top competitors include Pharmaron, Pfizer and Lonza.

Vidgas offers API Intermediates and ((3aR,4R,6R,6aR)-2,2-dimethyl-6-(2-oxo-4-(1H-1,2,4-triazol-1-yl)pyrimidin-1(2H)-yl)tetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methyl isobutyrate.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available